SHENZHEN, China , Aug. 30, 2023 /PRNewswire/ — LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the “Group”) for the six months ended 30 June 2023 (the “Reporting […]
Other News
European Society of Cardiology Congress: Traditional Chinese Medicine Qili Qiangxin significantly reduces the risk of cardiovascular death and re-hospitalization due to heart failure
AMSTERDAM, Aug. 30, 2023 /PRNewswire/ — The latest study indicates that adding TCM Qili Qiangxin Capsules (developed and produced by Yiling Pharmaceutical) to the standard of care for heart failure can significantly reduce the risk of re-hospitalization due to worsening heart failure and cardiovascular death in patients with chronic heart failure. On August […]
Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
NEW YORK, Aug. 30, 2023 /PRNewswire/ — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) to prevent heart attacks, strokes and deaths due to blood clots in patients with certain rare medical conditions, today announced the expanded evaluation of tecarfarin for the treatment […]
ConcertAI’s TeraRecon Adds Cardio Suite to its Eureka Clinical AI Platform
CAMBRIDGE, Mass., Aug. 30, 2023 /PRNewswire/ — Concert AI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced today that its Eureka Clinical AI platform’s Cardio Suite now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to help identify, treat, and manage cardiovascular disease. Eureka Clinical AI […]
Professor J Mocco to Join Protembis’ Board of Directors
AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the appointment of Professor J Mocco MD, MS, FAANS, FAHA of Icahn School of Medicine at Mount Sinai, NY, USA as an independent member of their Board of Directors. “I am delighted to welcome Professor Mocco […]
Radiaction Medical Raises $12.6 Million in Series C2 Funding and Elects Christopher Barys as a New Member to Its Board of Directors
TEL AVIV, Israel–(BUSINESS WIRE)–Radiaction Medical, LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today made two announcements. First, it has raised $12.6 million in Series C2 funding led by U.S. private equity fund InnovaHealth Partners with participation from additional co-investors. […]
For Realizing Vision of ZERO Cerebro-Cardiovascular Events, OMRON Healthcare Sponsors First Annual Meeting of AF Screen International Collaboration
KYOTO, Japan, Aug. 29, 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko, Kyoto Prefecture, has announced the official sponsorship of the first annual meeting of the AF Screen International Collaboration, a collaborative group that was established to promote discussion and research about screening for unknown […]
BIOTRONIK, INC. Announces First US Implant of Next-Generation Amvia Edge Pacemaker
LAKE OSWEGO, Ore., Aug. 29, 2023 /PRNewswire/ — BIOTRONIK, a leader in implantable medical device technology, today announced its first US implantation of the new Amvia Edge pacemaker. The procedure was successfully completed by Dr. Raul Weiss at Mount Sinai Medical Center in Miami, Florida. Amvia Edge is BIOTRONIK’s next-generation pacemaker family, featuring MRI Guard 24/7, […]
Haemonetics Announces European Expansion for VASCADE® Vascular Closure System
BOSTON, Aug. 29, 2023 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has announced that for the first time, patients have been treated with the company`s VASCADE MVP® Venous Vascular Closure system in Germany. This marks the first use of the […]
Revolutionizing Cardiac MRI Examinations: Vista.ai and HekaBio Announce Japan Partnership
PALO ALTO, Calif., Aug. 29, 2023 /PRNewswire/ — Vista.ai, a pioneer in AI-assisted MRI solutions, and HekaBio K.K., a Japan-based healthcare investment, development and commercialization platform, have signed a strategic partnership agreement whereby HekaBio will market Vista.ai’s innovative One Click™ MRI in Japan. Vista.ai’s AI-enhanced One-click Workflow Optimization for Cardiac MRI Cardiac MRI (CMR) […]



